Back to all Programs

Past Event

Related Materials

Past Event

Chinese HIV Clinical Forum Educational Series 2020 - 2021

Review of DTG and BIC Registrational Studies -José R Arribas

Integrase inhibitors: A unique Mechanism of Action - José Luis Blanco Arévalo

The 2nd Generation INSTI usage - Fujie Zhang

Roundtable Discussion: Benefits of 2nd Generation INSTI in Routine Clinical Practice

State of the Art: Resistance to INSTI - Anne - Geneviève Marcelin, PharmD, PhD

Optimal Use of DTG in Treatment Experienced Patients - Chia-Jui Yang, MD

HIV Drug Resistance in Asia Clinical Application - Kiat Ruxrungtham, MD

Roundtable Discussion: Resistance Considerations in Optimal Use of INSTI

Recap the Second Edition

State of the Art: Clinical Pharmacology of INSTI - Andrea Calcagno

Adherence Considerations in Choice of ARV Regimens - Francois Venter

Switching ART to Improve Adherence: An Overview of Strategies - Chen Seong Wong

Roundtable Discussion: Strategies to Improve Drug Taking Behavior

State of the Art: INSTI Toxicities and Their Management

Recap the Third Edition

Managing Toxicities and Co-Morbidities

Roundtable Discussion: Optimal Management of INSTI Toxicity and Co-Morbidities in the Asian Setting

Recap of key points from the fourth edition

Caring for the patients with HIV and Hepatitis B/C Co-Infection

COVID-19 in HIV Patients - Lianguo Ruan, MD

Caring for the Patient with HIV and TB Co-Infection - Yinzhong Shen, MD

Prevalence of HIV/Hep B/C and HIV/TB Co-Infection in China and Neighboring Countries - Hongzhou Lu, MD, PhD